An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the cost and hospitalization burden for R/R ALL patients.

Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

In this webinar, a detailed discussion is done on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.

Speakers : Dr. Vineet Govinda Gupta ( Moderator ) ,Dr. Atul Sharma ( Panelist ) ,Dr. Abhishek Bansal ( Panelist )

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Expert meeting discussing management strategies and therapies for EGFR mutation-positive non-small cell lung cancer.

Speakers : Dr. Abhishek Bansal ( Panelist ) ,Dr. Atul Sharma ( Panelist ) ,Dr. Vineet Govinda Gupta ( Moderator )

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

Expert panel discusses targeted therapies and strategies for managing EGFR mutation-positive non-small cell lung cancer.

Speakers : Dr. Vineet Govinda Gupta ( Moderator ) ,Dr. Atul Sharma ( Panelist ) ,Dr. Abhishek Bansal ( Panelist )

Dacomitinib Case Presentation: Baseline Treatment and Current Status

Explore Dr. Viraj Nevrekar’s expert insights on Dacomitinib in NSCLC, covering baseline treatment approaches, efficacy, and real-world case studies.

Speakers : Dr Viraj Nevrekar- (Moderator)

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

Explore Dr. Viraj Nevrekar’s expert analysis on the molecular and clinical differences between EGFR Exon 19 deletion and Exon 21 L858R mutations in NSCLC.

Speakers : Dr. Viraj Nevrekar

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

Dr. Viraj Nevrekar discusses first-line combination therapy and overall survival data in NSCLC, covering immunotherapy, targeted therapy, and chemotherapy.

Speakers : Dr. Viraj Nevrekar

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

Explore Dr. Viraj Nevrekar’s analysis of the L858R mutation in advanced NSCLC through a retrospective cohort study, covering treatment outcomes, survival trends, and clinical outcomes

Speakers : Dr. Viraj Nevrekar

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )


Recommended News For You

AI Unlocks Benefits of Prostate Cancer Treatment.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

Dual-action mRNA vaccine takes aim at aggressive skin cancer

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Recommended Articles For You

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health  

The Genetics of Bernard Soulier Syndrome: What We Know so Far 

Everything You Need to Know About Leiomyomas: A Comprehensive Guide  

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survival rates for incurable larynx cancer investigated for first time

2.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

3.

Knowing about and avoiding bladder cancer.

4.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

5.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

1.

Evidence-Based Approaches in Hematology for Modern Medicine

2.

Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery

3.

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After 

4.

The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts

5.

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot